Relmada Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.
RLMD Key Statistics
Stock Snapshot
Relmada Therapeutics(RLMD) stock is priced at $6.45, giving the company a market capitalization of 675.49M. It carries a P/E multiple of -5.76.
As of 2026-07-13, Relmada Therapeutics(RLMD) stock has fluctuated between $6.28 and $6.51. The current price stands at $6.45, placing the stock +2.7% above today's low and -0.9% off the high.
The Relmada Therapeutics(RLMD)'s current trading volume is 2.13M, compared to an average daily volume of 3.18M.
In the last year, Relmada Therapeutics(RLMD) shares hit a 52-week high of $8.00 and a 52-week low of $0.55.
In the last year, Relmada Therapeutics(RLMD) shares hit a 52-week high of $8.00 and a 52-week low of $0.55.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.